Skip to main content
. 2020 Dec 4;9(12):868. doi: 10.3390/antibiotics9120868

Table 1.

Summary of patients on high dose (≥ 4 mg/kg/day) disulfiram (n = 33).

Patient ID M/F Age Weight (kg) Max Dose (mg/kg/day) Duration Infection & Other Conditions Other Rx Adverse Reaction Benefit
1 M 29 95 5.3 6 WK Bb Psych Y E
2 F 24 57 5.5 5 MO Bb, Bh PN, FAT Y
3 F 61 71 7
7
6 WK
4 WK
Bb PN, Psych, syncope Y
Y E
4 F 64 82 4.6 5 MO Bb FAT, Psych, Arth, LFT Y
5 M 59 64 5.8 6 WK Bb, Bm FAT Y
6 M 29 65 7.7 5 MO Bb, CRPS PN, FAT, Arth Y
7 F 27 106 7.1
9.4
6 WK
9 WK
Bb, Bd PN, FAT, Arth Y
Y E
8 F 62 60 8 11 WK Bb FAT, Psych, LFT, near syncope Y E
9 F 63 70 5.4 3 MO Bb, Bm FAT, hyperdynamic Y
10 M 59 100 3.3
5.0
4 MO
3 MO
Bb, Bm FAT Y
Y E
11 M 50 88 5.7
5.7
6 WK
12 WK
Bb, RMSF FAT Y E
Y E
12 F 66 54 9.3 14 WK Bb, Bm PN, FAT, Psych Y E
13 M 70 73 6.8 3 MO Bb PN, FAT, Psych Y
15 F 55 60 4.1 2 MO Bb, Bm PN, FAT, LFT Y E
16 M 21 60 8.3 12 WK Bb, Bm, Bh Psych, FAT, LFT Y E
17 M 52 103 7.3 10 WK Bb, Bm Psych Y
18 M 50 93 5.4 3 MO Bb, Bm Psych Y E
19 F 46 55 6.8 10 WK Bb, Bh azith, rifam FAT Y
20 F 34 60 6.25 6 MO Bb, OCD FAT, Psych unclear
21 F 62 75 6.7
6.7
6 WK
3 MO
Bb, Bh FAT Y
Y E
22 M 28 59 6.4 6 WK Bb, Bh, Imm Def N
23 F 63 34 7.1
3.6
2 MO
4 MO
Bb FAT, PN Psych Y
Y
24 F 48 64 4.9 8 MO Bb, Bm, POTS Psych, FAT, Arth Y
29 F 23 59 5.3 6 MO Bb FAT, Psych after d/c Y
34 F 51 59 6.4 7 WK Bb FAT, Arth Y
36 F 18 77 4.8 7 MO+ Bb PN Y
37 F 74 115 6.5
6.5
6 WK
3 MO+
(alt. mos. on & off)
Bb Y
Y
38 M 71 95 5.3 4 MO Bb LFT Y
39 F 59 63 6
2
5 MO
4 MO+
Bb, Bh azith+, rifam FAT, Arth, Psych N
Y
42 M 25 92 5.4 4 MO Bb, Bd, TBRF Psych Y
49 M 83 76 5.8
1.6
6 WK
2 MO+
Bb, Bm,
myopathy
syncope Y E
Y
re-bitten
50 F 37 66 7.5
3.8
0.6
0.6
6 WK
3 WK
2 WK
3 MO+
Bb, Bm Psych, FAT N
N
Y
Y
54 M 73 85 4.4 4 MO+ Bb, Bm, Bh mino, rifam Y
re-bitten